Report Detail
Global Simvastatin Drug Market Insights, Forecast to 2025
- RnM3521244 |
- 14 June, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Simvastatin, marketed under the trade name Zocor among others, is a lipid-lowering medication. It is used along with exercise, diet, and weight loss to decrease elevated lipid (fat) levels. It is also used to decrease the risk of heart problems in those at high risk. It is taken by mouth.
The global Simvastatin Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Simvastatin Drug market based on company, product type, end user and key regions.
This report studies the global market size of Simvastatin Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Simvastatin Drug in these regions.
This research report categorizes the global Simvastatin Drug market by top players/brands, region, type and end user. This report also studies the global Simvastatin Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Salerno Pharma
Teva Pharmaceutical
Aurobindo Pharma
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Biocon
Lupin Pharmaceuticals
Accord Healthcare
Mylan
Market size by Product
5mg
10mg
20mg
40mg
80mg
Market size by End User
Adult
Children(10-17 years)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Simvastatin Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Simvastatin Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Simvastatin Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Simvastatin Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Simvastatin Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Simvastatin Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Simvastatin Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Simvastatin Drug Market Size Growth Rate by Product
- 1.4.2 5mg
- 1.4.3 10mg
- 1.4.4 20mg
- 1.4.5 40mg
- 1.4.6 80mg
- 1.5 Market by End User
- 1.5.1 Global Simvastatin Drug Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Children(10-17 years)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Simvastatin Drug Market Size
- 2.1.1 Global Simvastatin Drug Revenue 2014-2025
- 2.1.2 Global Simvastatin Drug Sales 2014-2025
- 2.2 Simvastatin Drug Growth Rate by Regions
- 2.2.1 Global Simvastatin Drug Sales by Regions
- 2.2.2 Global Simvastatin Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Simvastatin Drug Sales by Manufacturers
- 3.1.1 Simvastatin Drug Sales by Manufacturers
- 3.1.2 Simvastatin Drug Sales Market Share by Manufacturers
- 3.1.3 Global Simvastatin Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Simvastatin Drug Revenue by Manufacturers
- 3.2.1 Simvastatin Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Simvastatin Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Simvastatin Drug Price by Manufacturers
- 3.4 Simvastatin Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Simvastatin Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Simvastatin Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Simvastatin Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Simvastatin Drug Sales by Product
- 4.2 Global Simvastatin Drug Revenue by Product
- 4.3 Simvastatin Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Simvastatin Drug Breakdown Data by End User
6 North America
- 6.1 North America Simvastatin Drug by Countries
- 6.1.1 North America Simvastatin Drug Sales by Countries
- 6.1.2 North America Simvastatin Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Simvastatin Drug by Product
- 6.3 North America Simvastatin Drug by End User
7 Europe
- 7.1 Europe Simvastatin Drug by Countries
- 7.1.1 Europe Simvastatin Drug Sales by Countries
- 7.1.2 Europe Simvastatin Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Simvastatin Drug by Product
- 7.3 Europe Simvastatin Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Simvastatin Drug by Countries
- 8.1.1 Asia Pacific Simvastatin Drug Sales by Countries
- 8.1.2 Asia Pacific Simvastatin Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Simvastatin Drug by Product
- 8.3 Asia Pacific Simvastatin Drug by End User
9 Central & South America
- 9.1 Central & South America Simvastatin Drug by Countries
- 9.1.1 Central & South America Simvastatin Drug Sales by Countries
- 9.1.2 Central & South America Simvastatin Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Simvastatin Drug by Product
- 9.3 Central & South America Simvastatin Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Simvastatin Drug by Countries
- 10.1.1 Middle East and Africa Simvastatin Drug Sales by Countries
- 10.1.2 Middle East and Africa Simvastatin Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Simvastatin Drug by Product
- 10.3 Middle East and Africa Simvastatin Drug by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Simvastatin Drug Products Offered
- 11.1.5 Merck Recent Development
- 11.2 Salerno Pharma
- 11.2.1 Salerno Pharma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Salerno Pharma Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Salerno Pharma Simvastatin Drug Products Offered
- 11.2.5 Salerno Pharma Recent Development
- 11.3 Teva Pharmaceutical
- 11.3.1 Teva Pharmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Pharmaceutical Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Pharmaceutical Simvastatin Drug Products Offered
- 11.3.5 Teva Pharmaceutical Recent Development
- 11.4 Aurobindo Pharma
- 11.4.1 Aurobindo Pharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Aurobindo Pharma Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Aurobindo Pharma Simvastatin Drug Products Offered
- 11.4.5 Aurobindo Pharma Recent Development
- 11.5 Dr. Reddy's Laboratories
- 11.5.1 Dr. Reddy's Laboratories Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Dr. Reddy's Laboratories Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Dr. Reddy's Laboratories Simvastatin Drug Products Offered
- 11.5.5 Dr. Reddy's Laboratories Recent Development
- 11.6 Zydus Pharmaceuticals
- 11.6.1 Zydus Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Zydus Pharmaceuticals Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Zydus Pharmaceuticals Simvastatin Drug Products Offered
- 11.6.5 Zydus Pharmaceuticals Recent Development
- 11.7 Biocon
- 11.7.1 Biocon Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Biocon Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Biocon Simvastatin Drug Products Offered
- 11.7.5 Biocon Recent Development
- 11.8 Lupin Pharmaceuticals
- 11.8.1 Lupin Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Lupin Pharmaceuticals Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Lupin Pharmaceuticals Simvastatin Drug Products Offered
- 11.8.5 Lupin Pharmaceuticals Recent Development
- 11.9 Accord Healthcare
- 11.9.1 Accord Healthcare Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Accord Healthcare Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Accord Healthcare Simvastatin Drug Products Offered
- 11.9.5 Accord Healthcare Recent Development
- 11.10 Mylan
- 11.10.1 Mylan Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Mylan Simvastatin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Mylan Simvastatin Drug Products Offered
- 11.10.5 Mylan Recent Development
12 Future Forecast
- 12.1 Simvastatin Drug Market Forecast by Regions
- 12.1.1 Global Simvastatin Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Simvastatin Drug Revenue Forecast by Regions 2019-2025
- 12.2 Simvastatin Drug Market Forecast by Product
- 12.2.1 Global Simvastatin Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Simvastatin Drug Revenue Forecast by Product 2019-2025
- 12.3 Simvastatin Drug Market Forecast by End User
- 12.4 North America Simvastatin Drug Forecast
- 12.5 Europe Simvastatin Drug Forecast
- 12.6 Asia Pacific Simvastatin Drug Forecast
- 12.7 Central & South America Simvastatin Drug Forecast
- 12.8 Middle East and Africa Simvastatin Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Simvastatin Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Simvastatin Drug. Industry analysis & Market Report on Simvastatin Drug is a syndicated market report, published as Global Simvastatin Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Simvastatin Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
